Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Heatwurx Inc. (PCSA : NSDQ)

• Company Description    Processa Pharmaceuticals, Inc. is focused on the development of drug products which intended to improve the survival and/or quality of life for patients who have unmet medical need. Processa Pharmaceuticals Inc., formerly known as Heatwurx Inc., is based in HANOVER, United States. Number of Employees: 10

• Price / Volume Information    Yesterday's Closing Price: $0.31 Daily Weekly Monthly 20 Day Moving Average: 6,021,504 shares Shares Outstanding: 56.64 (millions) Market Capitalization: $17.32 (millions) Beta: 1.45 52 Week High: $1.50 52 Week Low: $0.15 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -19.27% -21.39% 12 Week 41.51% 35.64% Year To Date -65.40% -69.76%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 601 21ST STREET SUITE 300 - VERO BEACH,FL 32960 USA ph: 772-453-2899 fax: 443-288-4420 ir@processapharma.com http://www.processapharmaceuticals.com

• General Corporate Information    Officers George Ng - Chief Executive Officer Russell Skibsted - Chief Financial Officer Khoso Baluch - Director James Neal - Director Geraldine Pannu - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 74275C304 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/19/26 Share - Related Items Shares Outstanding: 56.64 Most Recent Split Date: 1.00 (0.05:1) Beta: 1.45 Market Capitalization: $17.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.06 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.43 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/19/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.64 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 93.20% vs. Previous Quarter: 72.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/25 - -301.42 06/30/25 - -342.36 03/31/25 - -319.56 ROA 09/30/25 - -217.32 06/30/25 - -243.48 03/31/25 - -232.40 Current Ratio 09/30/25 - 3.76 06/30/25 - 3.45 03/31/25 - 2.93 Quick Ratio 09/30/25 - 3.76 06/30/25 - 3.45 03/31/25 - 2.93 Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Book Value 09/30/25 - 0.12 06/30/25 - 0.15 03/31/25 - 0.67 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©